JAK2 and acquired polycythemia vera: Overall mutational burden increased with age as expected, and secondary non-JAK2 driver mutations were found in 9/10 old PV patients, in contrast with young PV patients, where JAK2 V617F appeared to be the only disease-related mutation present (41).